FindTrial
Sign In

Study of Tumor Biomarkers and Their Association with Clinical and Pathological Features in Colorectal Cancer

Correlation of p53, HER2/neu, BRAF, and Ki67 Immunostains with clinical and histopathological characteristics in colorectal tumors - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099933
Enrollment
30
Registered
2025-12-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C189- Malignant neoplasm of colon, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Vinayaka Mission Kirupanandha Variyar Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All resected colorectal tumor specimens

Exclusion criteria

Exclusion criteria: Patients with incomplete medical records Nonavailability of tissue samples Presence of other malignancies IBD Neoadjuvant chemotherapy

Design outcomes

Primary

MeasureTime frame
Proportion of colorectal tumor cases showing positive immunohistochemical expression of p53, HER2/neu, BRAF, and Ki-67. Immunohistochemical expression levels of p53, HER2/neu, BRAF, and Ki-67 in colorectal tumor tissue samples.Timepoint: At the time of histopathological diagnosis—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Kiruthika P

Vinayaka Mission Kirupanandha Variyar Medical College and Hospitals

drselvipathology@gmail.com9842744313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026